Brief: Medmix AG Says FY 2024 Revenue CHF 483.9M
Feb 26 (Reuters) - medmix AG MEDX.S: MEDMIX AG - FY 2024 REVENUE AT CHF 483.9M, -0.6% (- 1.5% ORG. FX ADJUSTED.) MEDMIX AG - 2025 TRANSITION YEAR WITH FLAT ORGANIC REVENUE GROWTH, ADJUSTED EBITDA MARGIN 18% TO 19% MEDMIX AG - FY 2024 ADJUSTED. EBITDA MARGIN AT 19.1%, MEDMIX AG - PROPOSES AN ORDINARY DIVIDEND OF CHF 0.50 PER SHARE FOR 2024 Source text: [ID:] Further company coverage: MEDX.S ((Reuters.Briefs@thomsonreuters.com;))